Na Li - Researcher Profile | RDL Research Database

Publications

2 shown

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial

Shengli Xia , Yuntao Zhang , Yanxia Wang +29 more

2020 The Lancet Infectious Diseases 1200 citations

Rituximab monotherapy versus glucocorticoid therapy for adult minimal change disease: a retrospective study on noninferiority

Xiaoyun Li , Guangyu Yao , Yujiao Sun +5 more

Introduction To verify whether rituximab (RTX) monotherapy is noninferior to glucocorticoids in inducing and maintaining remission in adults with minimal change disease (MCD). M...

2025 Frontiers in Nephrology 0 citations

Frequent Co-Authors

Researcher Info

h-index: 1
Publications: 2
Citations: 1,200
Institution: National Vaccine and Serum Institute

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0001-9080-1300

Impact Metrics

h-index 1

h-index: Number of publications with at least h citations each.